Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Enrofloxacin
aniMedica GmbH
QJ01MA90
Enrofloxacin
50 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
enrofloxacin
Authorised
2012-04-20
Enrotron 50 mg/ml 1 von 18 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Enrotron 50 mg/ml Solution for injection for cattle, sheep, goats, pigs, dogs and cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE Enrofloxacin 50.0 mg EXCIPIENTS 1-Butanol 30.0 mg For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection. Clear, slightly yellowish to yellowish orange solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (calves) Sheep Goats Pigs Dogs Cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _ _ CALVES Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of _Pasteurella multocida, Mannheimia haemolytica_ and _Mycoplasma _ spp. Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli_ . Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli_ . Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of _Mycoplasma bovis_ . SHEEP Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli. _ Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli. _ Treatment of mastitis caused by enrofloxacin susceptible strains of _Staphylococcus aureus _ and _Escherichia coli. _ _ _ _ _ Enrotron 50 mg/ml 2 von 18 GOATS Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of _Pasteurella multocida _ and _Mannheimia haemolytica_ . Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli. _ Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli_ . Treatment of mastitis caused by enrofloxacin susceptible strains of _Staphylococcus aureus _ and _Escherichia coli. _ PIGS Treatment of infections of the respiratory tract caused by enrofloxacin susceptib Read the complete document